Literature DB >> 23128034

Inclusion of latent tuberculosis infection as a separate entity into the international classification of diseases.

Marc Tebruegge, Eeva Salo, Nicole Ritz, Beate Kampmann.   

Abstract

The 11th revision of the International Classification of Diseases (ICD-11) proposed by the WHO is currently in the consultation phase. In common with previous versions of the ICD this revised version does not contain a code for latent tuberculosis infection (LTBI), contrasting with the inclusion of a large number of codes for various manifestations of active tuberculosis (TB). Inclusion of a separate code for LTBI into ICD-11 is critically important for epidemiological, clinical and research purposes. On behalf of the Paediatric Tuberculosis Network European Trials group, we encourage colleagues worldwide who are caring for TB patients or are involved in TB research to join us in supporting the case for a long overdue ICD code for LTBI.

Entities:  

Keywords:  Respiratory Infection; Tuberculosis

Mesh:

Year:  2012        PMID: 23128034     DOI: 10.1136/thoraxjnl-2012-202824

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  5 in total

1.  Epidemiology of childhood tuberculosis in Switzerland between 1996 and 2011.

Authors:  Gabriela Oesch Nemeth; Johannes Nemeth; Ekkehardt Altpeter; Nicole Ritz
Journal:  Eur J Pediatr       Date:  2013-11-08       Impact factor: 3.183

2.  Tuberculosis contact investigation results among paediatric contacts in low-incidence settings in Finland.

Authors:  Antti Kontturi; Satu Kekomäki; Eeva Ruotsalainen; Eeva Salo
Journal:  Eur J Pediatr       Date:  2021-03-02       Impact factor: 3.183

3.  Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children.

Authors:  Michela Sali; Danilo Buonsenso; Delia Goletti; Pamela D'Alfonso; Antonella Zumbo; Giovanni Fadda; Maurizio Sanguinetti; Giovanni Delogu; Piero Valentini
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

4.  Availability and use of molecular microbiological and immunological tests for the diagnosis of tuberculosis in europe.

Authors:  Marc Tebruegge; Nicole Ritz; Karsten Koetz; Antoni Noguera-Julian; James A Seddon; Steven B Welch; Maria Tsolia; Beate Kampmann
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

5.  Pediatric Tuberculosis in Northern Sardinia.

Authors:  Maria Grazia Clemente; Elena Dore; Lidia Abis; Paola Molicotti; Stefania Zanetti; Paolina Olmeo; Roberto Antonucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-04-15       Impact factor: 2.576

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.